G. V. Larionov
G. V. Larionov has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Tatiana Obodzinskaya
Clinic “PlanetaMed
8 shared publications - V. O. Generalov
Medline LLC
8 shared publications - Angelina N. Aleksandrenkova
Clinic “PlanetaMed
7 shared publications - Tatiana P. Klyushnik
Medline LLC
5 shared publications - Тимур Русланович Садыков
Medical Center “PlanetaMed
4 shared publications - A. M. Yugay
“PlanetaMed” Medical Center
3 shared publications
Latest Publications
- 16 November 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (5)
Urinary organic acid metabolic patterns in children with autism spectrum disorder
Background. Autism spectrum disorder (ASD) is characterized by substantial biological heterogeneity, with disturbances in energy metabolism and mitochondrial function considered among the potential mechanisms involved in its pathogenesis. Urinary organic acid analysis provides an indirect assessment of interconnected metabolic pathways, although interpretation of individual metabolites is limited by their functional overlap. Therefore, a domain-oriented approach may be useful for evaluating integrated metabolic patterns in children with ASD. Objective. To conduct a comparative analysis of the metabolic domains of urinary organic acids and their combinations (patterns) associated with energy metabolism and mitochondrial function in children with ASD and typically developing children. Materials and Methods. In a single-center observational cross-sectional study, 200 children were examined: 105 with ASD (3–9 years) and 95 typically developing controls. Twenty-eight urinary organic acids were quantified by gas chromatography-mass spectrometry. Metabolites were grouped into four functional domains: carbohydrate, lipid, amino acid and tricarboxylic acid (TCA) cycle. Principal component analysis, logistic regression and ROC analysis were used to derive integral domain indices; between-group differences were assessed by Mann–Whitney U and χ 2 tests. Results. The amino acid domain (AUC = 0.923) and the TCA domain (AUC=0.868) showed the highest diagnostic performance, with abnormalities detected in 87.6 % and 80.0 % of ASD cases versus 12.6 % and 20.0 % in controls. Carbohydrate and lipid domains demonstrated moderate diagnostic value. ASD patients primarily exhibited combined patterns involving three or more domains, indicating widespread mitochondrial metabolic involvement. Conclusion. Domain-oriented analysis of urinary organic acids may provide a basis for metabolic stratification and personalized energy-targeted corrections.
- 16 November 2026
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 13 (5)
Urinary organic acid metabolic patterns in children with autism spectrum disorder
Background. Autism spectrum disorder (ASD) is characterized by substantial biological heterogeneity, with disturbances in energy metabolism and mitochondrial function considered among the potential mechanisms involved in its pathogenesis. Urinary organic acid analysis provides an indirect assessment of interconnected metabolic pathways, although interpretation of individual metabolites is limited by their functional overlap. Therefore, a domain-oriented approach may be useful for evaluating integrated metabolic patterns in children with ASD. Objective. To conduct a comparative analysis of the metabolic domains of urinary organic acids and their combinations (patterns) associated with energy metabolism and mitochondrial function in children with ASD and typically developing children. Materials and Methods. In a single-center observational cross-sectional study, 200 children were examined: 105 with ASD (3–9 years) and 95 typically developing controls. Twenty-eight urinary organic acids were quantified by gas chromatography-mass spectrometry. Metabolites were grouped into four functional domains: carbohydrate, lipid, amino acid and tricarboxylic acid (TCA) cycle. Principal component analysis, logistic regression and ROC analysis were used to derive integral domain indices; between-group differences were assessed by Mann–Whitney U and χ 2 tests. Results. The amino acid domain (AUC = 0.923) and the TCA domain (AUC=0.868) showed the highest diagnostic performance, with abnormalities detected in 87.6 % and 80.0 % of ASD cases versus 12.6 % and 20.0 % in controls. Carbohydrate and lipid domains demonstrated moderate diagnostic value. ASD patients primarily exhibited combined patterns involving three or more domains, indicating widespread mitochondrial metabolic involvement. Conclusion. Domain-oriented analysis of urinary organic acids may provide a basis for metabolic stratification and personalized energy-targeted corrections.
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , 115-122
Quality of life of parents of children with autism spectrum disorders
Objective. To establish a correlation between the severity of clinical symptoms in children diagnosed with autism spectrum disorders (ASDs) and the quality of life experienced by their parents, and identify potential targets for effective interventions in care. Material and methods. The study included a sample of 40 parents of children diagnosed with ASD and 37 parents of neurotypical children. The clinical and psychometric evaluation of the children with ASD was conducted using the Childhood Autism Rating Scale (CARS). Additionally, the Quality of Life in Autism Questionnaire (QoLA) was used to assess parents’ quality of life. Statistical analyses were performed using MS Excel and STATISTICA software, employing nonparametric methods. Results. The psychometric assessment using the CARS scale yielded an average score of 22.6±5.8 for the examined children, indicating a mild autism classification. The total QoLA score for parents of children with ASD was 132.6±25.8 points, compared with 171.8±23.6 points for parents of neurotypical children (p<0.001). The quality of life of parents, as assessed by Part B of the QoLA scale, was found to be correlated with the severity of ASD as measured by the CARS scale (p<0.05). The primary symptoms identified that negatively impacted the quality of life of parents included the social impairments associated with autism, challenges in collaborative engagement, a lack of comprehension regarding social rules and roles, alongside communication disorders (p<0.05). Conclusions. The findings highlight potential targets for social and therapeutic interventions with families, which may alleviate parental distress and enhance the quality of life for parents of children diagnosed with ASD.
- 7 August 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (7) , 115-122
Quality of life of parents of children with autism spectrum disorders
Objective. To establish a correlation between the severity of clinical symptoms in children diagnosed with autism spectrum disorders (ASDs) and the quality of life experienced by their parents, and identify potential targets for effective interventions in care. Material and methods. The study included a sample of 40 parents of children diagnosed with ASD and 37 parents of neurotypical children. The clinical and psychometric evaluation of the children with ASD was conducted using the Childhood Autism Rating Scale (CARS). Additionally, the Quality of Life in Autism Questionnaire (QoLA) was used to assess parents’ quality of life. Statistical analyses were performed using MS Excel and STATISTICA software, employing nonparametric methods. Results. The psychometric assessment using the CARS scale yielded an average score of 22.6±5.8 for the examined children, indicating a mild autism classification. The total QoLA score for parents of children with ASD was 132.6±25.8 points, compared with 171.8±23.6 points for parents of neurotypical children (p<0.001). The quality of life of parents, as assessed by Part B of the QoLA scale, was found to be correlated with the severity of ASD as measured by the CARS scale (p<0.05). The primary symptoms identified that negatively impacted the quality of life of parents included the social impairments associated with autism, challenges in collaborative engagement, a lack of comprehension regarding social rules and roles, alongside communication disorders (p<0.05). Conclusions. The findings highlight potential targets for social and therapeutic interventions with families, which may alleviate parental distress and enhance the quality of life for parents of children diagnosed with ASD.
- 29 January 2026
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
- Vol. 34 (1) , 66-78
The Role of Dietary Factors in Prevention of Age-Related Cognitive Impairment: A Descriptive Literature Review
Introduction: No effective pharmaceutical treatment for age-related cognitive impairment and dementia is available nowadays, so prevention plays a key role. Objective: To summarize published data on the influence of various dietary factors on cognitive functions and associated pathological processes. Materials and Methods: We searched for publications on the topic issued over the previous 36 years in the MEDLINE and Google Scholar electronic databases, selected 72 studies containing an empirical assessment of the role of nutritional factors in preventing age-related cognitive disorders, and performed their descriptive analysis. Results: Excessive intake of added and refined sugars is associated with impaired cognitive performance; increased intake of omega-3 polyunsaturated fatty acids is associated with a lower risk of age-related cognitive decline while saturated fats pose a higher risk. High protein intake has been shown to correlate with better cognitive outcomes. Tyrosine and tryptophan have a positive effect on memory and reaction time so their high intake mitigates the risks of cognitive decline and Alzheimer’s disease by reducing oxidative stress. Vitamin D deficiency is linked to an increased risk of cognitive impairments. Adequate polyphenol intake demonstrates neuroprotective, neuroplastic, and anti-inflammatory effects. Dietary adherence determines cognitive outcomes: commitment to the Mediterranean diet is associated with a lower risk of mild cognitive impairment and Alzheimer’s disease. The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay was developed by scientists to reduce the risk of cognitive impairments, as well as to slow brain aging and prevent Alzheimer’s disease. The ketogenic/low-carbohydrate diet improves memory. The Western-style diet is associated with accelerated cognitive decline and an increased risk of dementia; it enhances inflammation and vascular-metabolic risk factors. Conclusions: Most studies suggest potential benefits of consuming certain micronutrients for cognitive health and lower risks of age-related cognitive disorders in different groups of population. Changes in modifiable lifestyle factors and, above all, nutrition are key strategies for maintaining brain health in aging.
- 29 January 2026
- Published by Federal Center for Hygiene and Epidemiology in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
- Vol. 34 (1) , 66-78
The Role of Dietary Factors in Prevention of Age-Related Cognitive Impairment: A Descriptive Literature Review
Introduction: No effective pharmaceutical treatment for age-related cognitive impairment and dementia is available nowadays, so prevention plays a key role. Objective: To summarize published data on the influence of various dietary factors on cognitive functions and associated pathological processes. Materials and Methods: We searched for publications on the topic issued over the previous 36 years in the MEDLINE and Google Scholar electronic databases, selected 72 studies containing an empirical assessment of the role of nutritional factors in preventing age-related cognitive disorders, and performed their descriptive analysis. Results: Excessive intake of added and refined sugars is associated with impaired cognitive performance; increased intake of omega-3 polyunsaturated fatty acids is associated with a lower risk of age-related cognitive decline while saturated fats pose a higher risk. High protein intake has been shown to correlate with better cognitive outcomes. Tyrosine and tryptophan have a positive effect on memory and reaction time so their high intake mitigates the risks of cognitive decline and Alzheimer’s disease by reducing oxidative stress. Vitamin D deficiency is linked to an increased risk of cognitive impairments. Adequate polyphenol intake demonstrates neuroprotective, neuroplastic, and anti-inflammatory effects. Dietary adherence determines cognitive outcomes: commitment to the Mediterranean diet is associated with a lower risk of mild cognitive impairment and Alzheimer’s disease. The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay was developed by scientists to reduce the risk of cognitive impairments, as well as to slow brain aging and prevent Alzheimer’s disease. The ketogenic/low-carbohydrate diet improves memory. The Western-style diet is associated with accelerated cognitive decline and an increased risk of dementia; it enhances inflammation and vascular-metabolic risk factors. Conclusions: Most studies suggest potential benefits of consuming certain micronutrients for cognitive health and lower risks of age-related cognitive disorders in different groups of population. Changes in modifiable lifestyle factors and, above all, nutrition are key strategies for maintaining brain health in aging.
- Open Access
- 18 September 2025
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 6 (3) , 73-86
Personalized Biomedical Intervention and Rehabilitation of Autism Spectrum Disorder Patients
Background. Modern scientific research have identified the most important biological components and pathological processes that contribute to the causes and development of an autistic specter disorder (ASD). However, autism management using psychological and pedagogical methods are of greater importance rather than medical examination and treatment. The purpose of the present study was to analyze the dynamics of ASD-related psychoneurological and laboratory indicators during the treatment using biomedical technologies. Materials and methods. The study included 68 children with moderate and severe ASD. In this work, psychopathological, psychometric, clinical, laboratory and statistical methods were used. Results revealed a pro-inflammatory state, heterogeneous changes in metabolic status, endocrine dysfunction with various degrees of impairment compensation. Personalized biomedical intervention helps to reduce the severity of psychoneurological symptoms and improve physical well-being, which is confirmed by laboratory tests. Conclusion. Interventions aimed at eliminating inner factors contributing to homeostasis disorders such as inflammation, metabolic dysfunction and hormonal imbalance contribute to the age- and gender-specific innate behavioral patterns, which results in successful outcomes in terms of normal child development. Keywords: autism spectrum disorder; neuroinflammation; metabolic dysfunction; hormonal imbalance; behavioral patterns; rehabilitation
- 18 September 2025
- Published by Research Institute for Healthcare Organization and Medical Management in City Healthcare
- Vol. 6 (3) , 73-86
Open AccessPersonalized Biomedical Intervention and Rehabilitation of Autism Spectrum Disorder Patients
Background. Modern scientific research have identified the most important biological components and pathological processes that contribute to the causes and development of an autistic specter disorder (ASD). However, autism management using psychological and pedagogical methods are of greater importance rather than medical examination and treatment. The purpose of the present study was to analyze the dynamics of ASD-related psychoneurological and laboratory indicators during the treatment using biomedical technologies. Materials and methods. The study included 68 children with moderate and severe ASD. In this work, psychopathological, psychometric, clinical, laboratory and statistical methods were used. Results revealed a pro-inflammatory state, heterogeneous changes in metabolic status, endocrine dysfunction with various degrees of impairment compensation. Personalized biomedical intervention helps to reduce the severity of psychoneurological symptoms and improve physical well-being, which is confirmed by laboratory tests. Conclusion. Interventions aimed at eliminating inner factors contributing to homeostasis disorders such as inflammation, metabolic dysfunction and hormonal imbalance contribute to the age- and gender-specific innate behavioral patterns, which results in successful outcomes in terms of normal child development. Keywords: autism spectrum disorder; neuroinflammation; metabolic dysfunction; hormonal imbalance; behavioral patterns; rehabilitation
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 7-15
Factors supporting chronic inflammation in mental illness
The presented literature review addresses factors and mechanisms of their influence on chronic inflammation throughout life, aggravating the severity of mental illness and contributing to its progression. Such factors include infections, intestinal microbiome disorders, lack of physical activity, overweight, chronic stress, and metabolic imbalance. Targeting these factors, in addition to standard drug therapy, can contribute to a mild course of the disease, improve the quality and duration of remissions, and, in some cases, overcome resistance to therapy.
- 29 August 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (8) , 7-15
Factors supporting chronic inflammation in mental illness
The presented literature review addresses factors and mechanisms of their influence on chronic inflammation throughout life, aggravating the severity of mental illness and contributing to its progression. Such factors include infections, intestinal microbiome disorders, lack of physical activity, overweight, chronic stress, and metabolic imbalance. Targeting these factors, in addition to standard drug therapy, can contribute to a mild course of the disease, improve the quality and duration of remissions, and, in some cases, overcome resistance to therapy.
- Open Access
- 24 October 2023
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 21 (5) , 56-66
Neuroinflammation as a Main Etiopathogenetic Factor in the Development of Drug-Resistant Epilepsies and Epileptic Encephalopathies
Background: despite the large number of newly emerging antiepileptic drugs, the frequency of treatment-resistant forms of epilepsy has not decreased, averaging 25–30%. Moreover the number of epileptic encephalopathies of early childhood has increased. One of the reasons of drug resistance is neuroinflammation. Aim: to evaluate the role of neuroinflammation in the pathogenesis of severe forms of childhood epilepsy and resistant adult epilepsy.Patients and methods: the main group 1 — 94 pediatric patients with epileptic encephalopathies, average age 20.4 ± 6.2 months. The control group 1 — 42 pediatric patients in remission of epilepsy, average age 21.3 ± 5.7 months. The main group 2 — 35 adult patients with resistant forms of epilepsy, average age 38.3 ± 7.9 years. The control group 2 — adult patients in remission of epilepsy 47 patients, average age 34.2 ± 8.6 years. The following blood levels were analyzed: neuron-specific enolase, S100 protein, eosinophilic cationic protein, IgE total level, total level of circulating immune complexes, leukocyte elastase and alpha-1 antitrypsin. Results: in the group of children with epileptic encephalopathies, an increase in neuroinflammation indicators was revealed in most patients. The average level of neuron-specific enolase is 27.6 ± 5.3 ng/ml compared to 14.2 ± 3.5 ng/ml in the control group. The average S100 protein level is 0.232 ± 0.041 ng/ml compared to 0.092 ± 0.024 ng/ml in the control group. The average level of eosinophilic cationic protein is 39.7 ± 9.4 ng/ml compared with 18.2 ± 5.3 ng/ml in the control group. The average IgE level is 157.3 ± 64.2 IU/ml compared to 42.2 ± 17.5 IU/ml in the control group. The average level of circulating immune complexes is 265.6 ± 54.4 UE/ml compared to 56.8 ± 16.8 UE/ml in the control group. In the group of adult patients with resistant forms of epilepsy, an increase in neuroinflammation indicators was revealed in most patients. The average level of neuron-specific enolase is 19.2 ± 7.2 ng/ml compared to 13.1 ± 4.1 ng/ml in the control group. The average S100 protein level is 0.115 ± 0.037 ng/ml compared to 0.093 ± 0.018 ng/ml in the control group. The average level of eosinophilic cationic protein is 24.2 ± 6.7 ng/ml compared to 18.8 ± 4.7 ng/ml in the control group. The average level of total IgE is 117.9 ± 32.6 IU/ml compared to 53.4 ± 18.2 IU/ml in the control group. The average level of circulating immune complexes is 235.2 ± 43.7 UE/ml compared to 62.6 ± 20.4 UE/ml in the control group. The level of leukocyte elastase was increased in 32 (91.4%) patients, the average level was 267.2 ± 36.8 nmol/min × ml compared with 175.2 ± 23.8 nmol/min × ml in the control group. The level of alpha-1 antitrypsin was increased in 33 (94.3%) patients, the average level was 55.2 ± 12.1 ng/ml compared with 26.4 ± 15.6 ng/ml in the control group. Conclusion: neuroinflammation is the factor of the development of severe forms of epilepsy and the formation of resistance in epileptic encephalopathies. Epileptic encephalopathies of early childhood according to their etiopathogenesis should be considered as subacute encephalitis, where seizures are only one sign of the pathological inflammatory process. The main clinical aim of the treatment of epileptic encephalopathies is the diagnosis of cumulative antigenic load and the selection of anti-inflammatory therapy.
- 24 October 2023
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 21 (5) , 56-66
Open AccessNeuroinflammation as a Main Etiopathogenetic Factor in the Development of Drug-Resistant Epilepsies and Epileptic Encephalopathies
Background: despite the large number of newly emerging antiepileptic drugs, the frequency of treatment-resistant forms of epilepsy has not decreased, averaging 25–30%. Moreover the number of epileptic encephalopathies of early childhood has increased. One of the reasons of drug resistance is neuroinflammation. Aim: to evaluate the role of neuroinflammation in the pathogenesis of severe forms of childhood epilepsy and resistant adult epilepsy.Patients and methods: the main group 1 — 94 pediatric patients with epileptic encephalopathies, average age 20.4 ± 6.2 months. The control group 1 — 42 pediatric patients in remission of epilepsy, average age 21.3 ± 5.7 months. The main group 2 — 35 adult patients with resistant forms of epilepsy, average age 38.3 ± 7.9 years. The control group 2 — adult patients in remission of epilepsy 47 patients, average age 34.2 ± 8.6 years. The following blood levels were analyzed: neuron-specific enolase, S100 protein, eosinophilic cationic protein, IgE total level, total level of circulating immune complexes, leukocyte elastase and alpha-1 antitrypsin. Results: in the group of children with epileptic encephalopathies, an increase in neuroinflammation indicators was revealed in most patients. The average level of neuron-specific enolase is 27.6 ± 5.3 ng/ml compared to 14.2 ± 3.5 ng/ml in the control group. The average S100 protein level is 0.232 ± 0.041 ng/ml compared to 0.092 ± 0.024 ng/ml in the control group. The average level of eosinophilic cationic protein is 39.7 ± 9.4 ng/ml compared with 18.2 ± 5.3 ng/ml in the control group. The average IgE level is 157.3 ± 64.2 IU/ml compared to 42.2 ± 17.5 IU/ml in the control group. The average level of circulating immune complexes is 265.6 ± 54.4 UE/ml compared to 56.8 ± 16.8 UE/ml in the control group. In the group of adult patients with resistant forms of epilepsy, an increase in neuroinflammation indicators was revealed in most patients. The average level of neuron-specific enolase is 19.2 ± 7.2 ng/ml compared to 13.1 ± 4.1 ng/ml in the control group. The average S100 protein level is 0.115 ± 0.037 ng/ml compared to 0.093 ± 0.018 ng/ml in the control group. The average level of eosinophilic cationic protein is 24.2 ± 6.7 ng/ml compared to 18.8 ± 4.7 ng/ml in the control group. The average level of total IgE is 117.9 ± 32.6 IU/ml compared to 53.4 ± 18.2 IU/ml in the control group. The average level of circulating immune complexes is 235.2 ± 43.7 UE/ml compared to 62.6 ± 20.4 UE/ml in the control group. The level of leukocyte elastase was increased in 32 (91.4%) patients, the average level was 267.2 ± 36.8 nmol/min × ml compared with 175.2 ± 23.8 nmol/min × ml in the control group. The level of alpha-1 antitrypsin was increased in 33 (94.3%) patients, the average level was 55.2 ± 12.1 ng/ml compared with 26.4 ± 15.6 ng/ml in the control group. Conclusion: neuroinflammation is the factor of the development of severe forms of epilepsy and the formation of resistance in epileptic encephalopathies. Epileptic encephalopathies of early childhood according to their etiopathogenesis should be considered as subacute encephalitis, where seizures are only one sign of the pathological inflammatory process. The main clinical aim of the treatment of epileptic encephalopathies is the diagnosis of cumulative antigenic load and the selection of anti-inflammatory therapy.
- Open Access
- 24 October 2023
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 21 (5) , 47-55
Neuroinflammation Process as a Key Etiopathogenetic Factor in the Evolution of Autism Spectrum Disorders in Child Patients
Background: the prevalence of autism spectrum disorders (ASD) is increasing every year, however, diagnostic and therapeutic options are still limited. Aim: identification the patterns of the neuroinflammation process in the etiopathogenesis of ASD of child patients. Patients and methods: clinical, anamnestic and laboratory data of 85 child patients with a confirmed ASD diagnosis. Each patient was assessed for the level of neurospecific proteins (neuron-specific enolase (NSE), S100b protein), the indices of the “Neuro-immuno-test” panel (leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) activity, autoantibodies to S100b protein and myelin basic protein) in the blood before and after a standardized three-month-course of treatment. The reference interval of the laboratory was taken as normal values. The clinical picture was assessed according to the Childhood Autism Rating Scale (CARS). The correlation calculations were carried out in the MS Excel program. Results: in this work we describe the dynamics of the neuroinflammation process parameters in children with autism-like syndrome and psycho-speech development delay on the basis of complex anti-inflammatory therapy. The results of the research prove the increase in NSE and S100b protein quantity among 85% of patients before the treatment. More than 60% of patients had the increase of the parameters of the Neuro-test panel. The severity levels of symptoms among patients according to the scales used specified moderate and severe autism. The quantity of neurospecific proteins and immunological parameters correlated with CARS scale scores. Positive dynamics of clinical symptoms and studied parameters decrease were observed while therapy. The use of the parameters allows to evaluate objectively the severity levels of the patient’s immunomitochondrial status and shows a congruent change on the basis of etiopathogenetic therapy.
- 24 October 2023
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 21 (5) , 47-55
Open AccessNeuroinflammation Process as a Key Etiopathogenetic Factor in the Evolution of Autism Spectrum Disorders in Child Patients
Background: the prevalence of autism spectrum disorders (ASD) is increasing every year, however, diagnostic and therapeutic options are still limited. Aim: identification the patterns of the neuroinflammation process in the etiopathogenesis of ASD of child patients. Patients and methods: clinical, anamnestic and laboratory data of 85 child patients with a confirmed ASD diagnosis. Each patient was assessed for the level of neurospecific proteins (neuron-specific enolase (NSE), S100b protein), the indices of the “Neuro-immuno-test” panel (leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) activity, autoantibodies to S100b protein and myelin basic protein) in the blood before and after a standardized three-month-course of treatment. The reference interval of the laboratory was taken as normal values. The clinical picture was assessed according to the Childhood Autism Rating Scale (CARS). The correlation calculations were carried out in the MS Excel program. Results: in this work we describe the dynamics of the neuroinflammation process parameters in children with autism-like syndrome and psycho-speech development delay on the basis of complex anti-inflammatory therapy. The results of the research prove the increase in NSE and S100b protein quantity among 85% of patients before the treatment. More than 60% of patients had the increase of the parameters of the Neuro-test panel. The severity levels of symptoms among patients according to the scales used specified moderate and severe autism. The quantity of neurospecific proteins and immunological parameters correlated with CARS scale scores. Positive dynamics of clinical symptoms and studied parameters decrease were observed while therapy. The use of the parameters allows to evaluate objectively the severity levels of the patient’s immunomitochondrial status and shows a congruent change on the basis of etiopathogenetic therapy.
- Open Access
- 23 October 2023
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 21 (5) , 17-24
Neuroinflammatory Part of the Systemic Inflammatory Process in the Development of Neurodegenerative Conditions
Background: neurodegenerative processes are prognostically dramatic conditions. They are actively studied by both neurologists and psychiatrists. Nosological forms are diverse and include regressive autism, dementia, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, progressive epilepsy of infancy and childhood, generalized hyperkinesis, Tourette’s syndrome and many other conditions that are common to progressive neurological deficit, loss of cognitive functions, the appearance of nonspecific symptoms of brain irritation (epileptic seizures, hyperkinesis, dystonic states, stereotypes, psychotic episodes and other symptoms). Despite many ongoing studies the treatment of the described conditions is limited to temporary, incomplete and pharmacologically dependent relief of symptoms, since the problem of the etiopathogenesis of these conditions remains open. The aim of review is to present current immunological concepts of pathogenesis of neurodegenerative diseases. Material and method: using keywords “neuroinflammation, neurodegeneration, multiple sclerosis, Parkinson disease, epilepsy, parasitosis, microbiota” selected relevant scientific publications in domestic and international databases. Conclusion: recent advances in neuroimmunology show a significant role of neuroinflammation in the triggering and development of neurodegenerative processes, some of which are autoimmune in nature, which is confirmed by the indicators of immunity intensity introduced into clinical practice and by the detected antibody titers to brain tissues. In recent decades in a series of scientific works attention has been paid to the study of infectious agents detected in the immunological screening of patients with neurodegeneration, however, these data are fragmented and contradictory, and therefore are ignored by the medical community. This review presents a modern view of the etiopathogenesis of neurodegenerative diseases from the point of view of the summative antigenic burden, assessment of the immunological potential, homeostatic resource, and compensatory capabilities of the human body, which as a result can become a starting point for proposing new therapeutic strategies for the treatment of these intractable diseases.
- 23 October 2023
- Published by Medical Informational Agency Publishers in Psychiatry (Moscow) (Psikhiatriya)
- Vol. 21 (5) , 17-24
Open AccessNeuroinflammatory Part of the Systemic Inflammatory Process in the Development of Neurodegenerative Conditions
Background: neurodegenerative processes are prognostically dramatic conditions. They are actively studied by both neurologists and psychiatrists. Nosological forms are diverse and include regressive autism, dementia, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, progressive epilepsy of infancy and childhood, generalized hyperkinesis, Tourette’s syndrome and many other conditions that are common to progressive neurological deficit, loss of cognitive functions, the appearance of nonspecific symptoms of brain irritation (epileptic seizures, hyperkinesis, dystonic states, stereotypes, psychotic episodes and other symptoms). Despite many ongoing studies the treatment of the described conditions is limited to temporary, incomplete and pharmacologically dependent relief of symptoms, since the problem of the etiopathogenesis of these conditions remains open. The aim of review is to present current immunological concepts of pathogenesis of neurodegenerative diseases. Material and method: using keywords “neuroinflammation, neurodegeneration, multiple sclerosis, Parkinson disease, epilepsy, parasitosis, microbiota” selected relevant scientific publications in domestic and international databases. Conclusion: recent advances in neuroimmunology show a significant role of neuroinflammation in the triggering and development of neurodegenerative processes, some of which are autoimmune in nature, which is confirmed by the indicators of immunity intensity introduced into clinical practice and by the detected antibody titers to brain tissues. In recent decades in a series of scientific works attention has been paid to the study of infectious agents detected in the immunological screening of patients with neurodegeneration, however, these data are fragmented and contradictory, and therefore are ignored by the medical community. This review presents a modern view of the etiopathogenesis of neurodegenerative diseases from the point of view of the summative antigenic burden, assessment of the immunological potential, homeostatic resource, and compensatory capabilities of the human body, which as a result can become a starting point for proposing new therapeutic strategies for the treatment of these intractable diseases.